A 30-Second Public Evidence Risk Checklist for Popular AI Stocks
Before buying or selling a popular AI stock, check the public evidence first. FlowHunt turns FINRA, SEC, CBOE, market breadth, price-volume and volatility data into a simple risk checklist.
Popular AI stocks move fast. Public evidence is scattered.
Forecasts are noisy, price targets are often late, and headlines can be emotional. A checklist helps investors slow down before acting.
FlowHunt does not tell you what to buy or sell. It helps you see which public evidence deserves attention before you make your own decision.
Public Evidence We Track
Trend position, volume stress and momentum context.
Whether AI leaders and the broader market are weakening together.
Implied volatility, put/call context and event risk.
Short sale volume, Form 4, 13F and fails-to-deliver records.
Risk Temperature Is Not a Buy or Sell Signal
Evidence concentration, not a trading signal
Elevated does not mean sell. Cooling does not mean buy. It simply tells you where to look next.
Popular AI Stock Risk Checklists
Learn the Evidence Layers
FAQ
Is this a stock forecast tool?
No. FlowHunt does not predict prices. It organizes public risk evidence for research purposes only.
Is the risk temperature a buy or sell signal?
No. It only shows whether public risk evidence appears more concentrated.
Is FINRA short sale volume the same as short interest?
No. FINRA short sale volume is not short interest and can include market-making or hedging activity.
Can 13F filings show real-time institutional buying?
No. 13F filings are delayed quarterly disclosures and should be treated as slow-moving context.
Are fails-to-deliver records proof of naked short selling?
No. FTD records can result from multiple causes and should be treated as one risk clue, not proof.
This page organizes public market data and public disclosure records for research and review purposes only. It does not provide investment advice, trading recommendations, price forecasts or any promise of returns. FINRA short sale volume, SEC Form 4, 13F, FTD, options, market breadth and price-volume data all have reporting lags, methodology limits and scope limitations. No single indicator should be used as a standalone trading decision.